|
1
|
Casali PG, Blay JY, Abecassis N, Bajpai J,
Bauer S, Biagini R, Bielack S, Bonvalot S, Boukovinas I, Bovee
JVMG, et al: Gastrointestinal stromal tumours:
ESMO-EURACAN-GENTURIS Clinical Practice Guid elines for diagnosis,
treatment and follow-up. Ann Oncol. 33:20–33. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Miettinen M and Lasota J: Gastrointestinal
stromal tumors: Review on morphology, molecular pathology,
prognosis, and differential diagnosis. Arch Pathol Lab Med.
130:1466–1478. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Peng F and Liu Y: Gastrointestinal stromal
tumors of the small intestine: Progress in diagnosis and treatment
research. Cancer Manag Res. 12:3877–3889. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Giuliano K, Nagarajan N, Canner J,
Najafian A, Wolfgang C, Schneider E, Meyer C, Lennon AM, Johnston
FM and Ahuja N: Gastric and small intestine gastrointestinal
stromal tumors: Do outcomes differ? J Surg Oncol. 115:351–357.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lopez Gordo S, Bettonica C, Miró M,
Estremiana F, Aranda H and Farran L: Gastric and small intestine
gist: Results of 156 cases in 20 years. J Gastrointest Cancer.
53:451–459. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Joensuu H, Vehtari A, Riihimäki J, Nishida
T, Steigen SE, Brabec P, Plank L, Nilsson B, Cirilli C, Braconi C,
et al: Risk of recurrence of gastrointestinal stromal tumour after
surgery: An analysis of pooled Population-based cohorts. Lancet
Oncol. 13:265–74. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Miettinen M and Lasota J: Gastrointestinal
stromal tumors. Gastroenterol Clin North Am. 42:399–415. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu TJ, Lee LY, Yeh CN, Wu PY, Chao TC,
Hwang TL, Jan YY and Chen MF: Surgical treatment and prognostic
analysis for gastrointestinal stromal tumors (GISTs) of the small
intestine: Before the era of imatinib mesylate. BMC Gastroenterol.
6:292006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhou Y, Hu W, Chen P, Abe M, Shi L, Tan
SY, Li Y and Zong L: Ki67 is a biological marker of malignant risk
of gastrointestinal stromal tumors: A systematic review and
meta-analysis. Medicine (Baltimore). 96:e79112017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wong NA, Young R, Malcomson RD, Nayar AG,
Jamieson LA, Save VE, Carey FA, Brewster DH, Han C and Al-Nafussi
A: Prognostic indicators for gastrointestinal stromal tumours: A
clinicopathological and immunohistochemical study of 108 resected
cases of the stomach. Histopathology. 43:118–126. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Narushima K, Shuto K, Okazumi S, Ohira G,
Mori M, Hayano K, Yanagawa N and Matsubara H: Malignant diagnosis
and prognostic analysis of 89 GIST patients using preoperative
FDG-PET. Sci Rep. 13:22662023. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cho MH, Park CK, Park M, Kim WK, Cho A and
Kim H: Clinicopathologic features and molecular characteristics of
glucose metabolism contributing to
¹8F-fluorodeoxyglucose uptake in gastrointestinal
stromal tumors. PLoS One. 10:e01414132015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Du W, Cui G, Wang K and Li S: Clinical
significance of 18F-FDG PET/CT imaging in 32 cases of
gastrointestinal stromal tumors. Eur J Med Res. 27:1822022.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Feng F, Tian Y, Liu S, Zheng G, Liu Z, Xu
G, Guo M, Lian X, Fan D and Zhang H: Combination of PLR, MLR, MWR,
and tumor size could significantly increase the prognostic value
for gastrointestinal stromal tumors. Medicine (Baltimore).
95:e32482016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang F, Tao T, Yu H, Xu Y, Yang Z, Xia X,
Wang M, Zong L and Guan W: Prognostic value of Onodera's
nutritional index for intermediate- and high-risk gastrointestinal
stromal tumors treated with or without tyrosine kinase inhibitors.
World J Surg Oncol. 19:2272021. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang H, Xu YY, You J, Hu WQ, Wang SF, Chen
P, Yang F, Shi L, Zhao W and Zong L: Onodera's Prognostic
Nutritional Index is a novel and useful prognostic marker for
gastrointestinal stromal tumors. World J Gastrointest Surg.
13:1202–1215. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ren W, Wang H, Xiang T and Liu G:
Prognostic role of preoperative Onodera's prognostic nutritional
index (OPNI) in gastrointestinal stromal tumors: A systematic
review and Meta-analysis. J Gastrointest Cancer. 54:731–738. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhou S, Abdihamid O, Tan F, Zhou H, Liu H,
Li Z, Xiao S and Li B: KIT mutations and expression: Current
knowledge and new insights for overcoming IM resistance in GIST.
Cell Commun Signal. 22:1532024. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Debiec-Rychter M, Sciot R, Le Cesne A,
Schlemmer M, Hohenberger P, van Oosterom AT, Blay JY, Leyvraz S,
Stul M, Casali PG, et al: KIT mutations and dose selection for
imatinib in patients with advanced gastrointestinal stromal
tumours. Eur J Cancer. 42:1093–103. 2006. View Article : Google Scholar : PubMed/NCBI
|
